Table 3 Distribution of genotypic, allelic frequencies, and genetic models of rs4953616 and rs7371084 polymorphisms between PCOS cases and controls.

From: Significance of LHCGR polymorphisms in polycystic ovary syndrome: an association study

SNP

Genotype/allele

Case (%)

Control (%)

χ2 p-value

OR (95% CI)

p-value

rs4953616

CC

92 (21)

100 (26.3)

1.0E−2*

Reference

CT

217 (49)

198 (52.1)

1.19 (0.84 to 1.67)

0.3

TT

134 (30)

82 (21.6)

1.77 (1.19 to 2.63)

4.0E−3*

C

401 (45.3)

398 (52.4)

4.0E−3*

Reference

T

485 (54.7)

362 (47.6)

1.3 (1.09 to 1.61)

4.0E−3*

Dominant model

TT + CT vs. CC

351/92

280/100

0.06

1.3 (0.98 to 1.88)

0.06

Recessive model

TT vs. CT + CC

134/309

82/298

4.0E−3*

1.5 (1.14 to 2.16)

5.0E−3*

Heterozygous model

CT vs. TT + CC

217/226

198/182

0.3

0.8 (0.67 to 1.16)

0.3

rs7371084

TT

397 (89.6)

329 (86.5)

0.25

Reference

TC

42 (9.4)

49 (13)

0.7 (0.45 to 1.09)

0.1

CC

4 (1)

2 (0.5)

1.6 (0.30 to 9.10)

0.5

T

836 (94.4)

707 (93)

0.26

Reference

C

50 (5.6)

53 (7)

0.7 (0.53 to 1.18)

0.2

Dominant model

CC + TC vs. TT

46/397

51/329

0.1

0.74 (0.48 to 1.14)

0.17

Recessive model

CC vs. TC + TT

4/439

2/378

0.5

1.7 (0.31 to 9.45)

0.5

Heterozygous model

TC vs. CC + TT

42/401

49/331

0.1

0.7 (0.45 to 1.09)

0.12

  1. χ2: chi-square; OR: odds ratio.
  2. *p-value considered significant after Bonferroni correction.